Healthcare provider profile · identity verified

Megan Eichstaedt, MD

Family Practice · WAUWATOSA, WI · NPI 1174083232

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	467	167
Amlodipine Besylate	Amlodipine Besylate	329	118
Levothyroxine Sodium	Levothyroxine Sodium	258	83
Losartan Potassium	Losartan Potassium	254	85
Lisinopril	Lisinopril	220	81
Omeprazole	Omeprazole	192	66
Rosuvastatin Calcium	Rosuvastatin Calcium	189	57
Furosemide	Furosemide	176	51
Metoprolol Succinate	Metoprolol Succinate	168	47
Gabapentin	Gabapentin	156	42
Pantoprazole Sodium	Pantoprazole Sodium	146	41
Hydrochlorothiazide	Hydrochlorothiazide	144	49
Potassium Chloride	Potassium Chloride	130	39
Metformin Hcl	Metformin Hcl	118	44
Ezetimibe	Ezetimibe	116	31
Pravastatin Sodium	Pravastatin Sodium	116	37
Sertraline Hcl	Sertraline Hcl	114	35
Albuterol Sulfate Hfa	Albuterol Sulfate	108	42
Metformin Hcl Er	Metformin Hcl	99	29
Trazodone Hcl	Trazodone Hcl	83	26
Eliquis	Apixaban	81	19
Metoprolol Tartrate	Metoprolol Tartrate	80	27
Simvastatin	Simvastatin	77	41
Tramadol Hcl	Tramadol Hcl	76	15
Fluticasone Propionate	Fluticasone Propionate	68	36
Terazosin Hcl	Terazosin Hcl	59	19
Allopurinol	Allopurinol	58	28
Escitalopram Oxalate	Escitalopram Oxalate	58	17
Meloxicam	Meloxicam	58	23
Oxycodone Hcl	Oxycodone Hcl	54	suppressed
Spironolactone	Spironolactone	53	14
Ozempic	Semaglutide	51	12
Zolpidem Tartrate	Zolpidem Tartrate	51	11
Carvedilol	Carvedilol	49	19
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	47	47
Diclofenac Sodium	Diclofenac Sodium	44	25
Duloxetine Hcl	Duloxetine Hcl	44	11
Glipizide Er	Glipizide	43	14
Fluoxetine Hcl	Fluoxetine Hcl	42	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	14
Famotidine	Famotidine	39	15
Bupropion Xl	Bupropion Hcl	37	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	11
Triamcinolone Acetonide	Triamcinolone Acetonide	37	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	13
Tamsulosin Hcl	Tamsulosin Hcl	36	suppressed
Atenolol	Atenolol	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	14
Montelukast Sodium	Montelukast Sodium	35	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	15
Lorazepam	Lorazepam	32	suppressed
Nifedipine Er	Nifedipine	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	16
Tizanidine Hcl	Tizanidine Hcl	31	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Jardiance	Empagliflozin	29	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Alendronate Sodium	Alendronate Sodium	26	12
Valsartan	Valsartan	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Alprazolam	Alprazolam	25	12
Mirtazapine	Mirtazapine	25	12
Donepezil Hcl	Donepezil Hcl	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	11
Glimepiride	Glimepiride	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Diazepam	Diazepam	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	21	21
Chlorthalidone	Chlorthalidone	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	21
Meclizine Hcl	Meclizine Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Linzess	Linaclotide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Cephalexin	Cephalexin	14	12
Clonazepam	Clonazepam	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Guanfacine Hcl	Guanfacine Hcl	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Azithromycin	Azithromycin	11	11
Fluconazole	Fluconazole	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glipizide	Glipizide	11	suppressed
Prednisone	Prednisone	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error